+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
All Ages
All Genders
ID02716246

Gene Transfer Trial of scAAV9.U1a.hSGSH for Treating Mucopolysaccharidosis IIIA in Children

Led by Ultragenyx Pharmaceutical Inc · Updated on 2026-09-22

36

Participants Needed

5

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of UX111 for treating Mucopolysaccharidosis IIIA MPS IIIA, a rare genetic condition. This open-label trial tests a single intravenous dose of a gene therapy called scAAV9.U1a.hSGSH. The study includes a dose-escalation design where participants receive varying doses of UX111 to assess response and safety. Some participants may also receive immunomodulatory therapy to support treatment, decided by investigators and caregivers. UX111 is administered once through a vein in a limb. The study involves up to four dosage groups, with doses ranging from 0.5 x 1013 to 3 x 1013 vector genomes per kilogram. Prophylactic immunomodulatory treatment is provided to all participants, with optional additional immunomodulatory therapy at certain sites depending on individual patient needs. This trial is conducted across multiple global locations and includes children from birth up to 5 years old, depending on the cohort. Participants will undergo regular assessments including neurological development tests like the Bayley Scales of Infant and Toddler Development, and laboratory tests measuring cerebrospinal fluid substances related to the disease. Researchers will monitor changes in brain volume and enzyme activity over 24 months. Safety and immune responses will be closely followed. The total study duration extends up to 24 months after treatment, with ongoing evaluations to understand the long-term effects of the gene therapy.

CONDITIONS

Brief Title

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Research Team

P

Patients Contact: Trial Recruitment

H

HCPs Contact: Medical Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here